Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5101
Global X Guru Index ETF
GURU
$59.4M
| $979K | ﹤0.01% |
13,979
-2,581
| -16% | -$169K |
2013 Q2
52 quarters
|
|
5102
Eve Holding
EVEX
$568M
| $978K | ﹤0.01% |
389,546
-310,985
| -44% | -$896K |
2022 Q2
16 quarters
|
|
5103
ECB Bancorp
ECBK
$173M
| $973K | ﹤0.01% |
48,447
+4,587
| +10% | +$84.8K |
2025 Q1
5 quarters
|
|
5104
iShares MSCI Denmark ETF
EDEN
$185M
| $973K | ﹤0.01% |
8,813
-354
| -4% | -$38.9K |
2014 Q4
46 quarters
|
|
5105
PIMCO Global StockPLUS & Income Fund
PGP
$94M
| $970K | ﹤0.01% |
112,576
-29,640
| -21% | -$260K |
2013 Q2
52 quarters
|
|
5106
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$41.4M
| $966K | ﹤0.01% |
15,106
-49
| -0.3% | -$3.38K |
2013 Q2
52 quarters
|
|
5107
ProShares VIX Short-Term Futures ETF
VIXY
$225M
| $965K | ﹤0.01% |
45,330
-42,183
| -48% | -$1.11M |
2013 Q3
51 quarters
|
|
5108
Park-Ohio Holdings
PKOH
$668M
| $964K | ﹤0.01% |
25,073
-12,726
| -34% | -$391K |
2013 Q2
52 quarters
|
|
5109
DELISTED
Forte Biosciences
FBRX
| $956K | ﹤0.01% |
45,007
-455,291
| -91% | -$10.8M |
2017 Q2
36 quarters
|
|
5110
Azul S.A.
AZUL
$1.23B
| $953K | ﹤0.01% |
+106,003
| New | +$936K |
2026 Q2
0 quarters
|
|
5111
Defi Technologies
DEFT
$165M
| $952K | ﹤0.01% |
1,850,935
+1,760,886
| +1,955% | +$1.19M |
2025 Q2
4 quarters
|
|
5112
DELISTED
IonQ Inc Warrants
IONQ.WS
| $952K | ﹤0.01% |
+23,000
| New | +$903K |
2026 Q2
0 quarters
|
|
5113
ProShares Ultra Silver
AGQ
$1.13B
| $949K | ﹤0.01% |
13,951
+11,988
| +611% | +$1.32M |
2013 Q3
51 quarters
|
|
5114
Invesco S&P 500 Value with Momentum ETF
SPVM
$137M
| $946K | ﹤0.01% |
12,710
+5,528
| +77% | +$398K |
2014 Q1
49 quarters
|
|
5115
Goldman Sachs Future Health Care Equity ETF
GDOC
$18.7M
| $945K | ﹤0.01% |
26,199
-2,900
| -10% | -$95.8K |
2026 Q1
1 quarter
|
|
5116
Roundhill Metaverse ETF
METV
$232M
| $942K | ﹤0.01% |
51,075
-945
| -2% | -$17.1K |
2021 Q3
19 quarters
|
|
5117
Invesco BulletShares 2032 High Yield Corporate Bond ETF
BSJW
$51.1M
| $942K | ﹤0.01% |
37,244
+36,244
| +3,624% | +$919K |
2026 Q1
1 quarter
|
|
5118
Mind CTI
MNDO
$19M
| $941K | ﹤0.01% |
913,887
-44,291
| -5% | -$44.5K |
2014 Q1
49 quarters
|
|
5119
Platinum Group Metals
PLG
$150M
| $939K | ﹤0.01% |
695,699
+298,414
| +75% | +$500K |
2013 Q4
50 quarters
|
|
5120
Senseonics Holdings Inc
SENS
$431M
| $937K | ﹤0.01% |
164,984
+41,041
| +33% | +$263K |
2016 Q3
39 quarters
|
|
5121
Northern Trust US Quality Large Cap ETF
QLC
$1.13B
| $934K | ﹤0.01% |
10,388
| – | – |
2020 Q3
23 quarters
|
|
5122
Designer Brands
DBI
$322M
| $932K | ﹤0.01% |
159,814
+10,610
| +7% | +$74.6K |
2013 Q2
52 quarters
|
|
5123
Saratoga Investment
SAR
$238M
| $931K | ﹤0.01% |
41,713
+13,427
| +47% | +$301K |
2013 Q2
52 quarters
|
|
5124
Trueblue
TBI
$253M
| $927K | ﹤0.01% |
132,946
+32,705
| +33% | +$182K |
2013 Q2
52 quarters
|
|
5125
Innovator US Equity 5 to 15 Buffer ETF Quarterly
EALT
$188M
| $926K | ﹤0.01% |
+25,825
| New | +$911K |
2026 Q2
0 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.